These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Further report on therapeutic effect of abrin and ricin on human cancers. Hsu CT; Lin JY; Tung TC Taiwan Yi Xue Hui Za Zhi; 1974 Sep; 73(9):526-42. PubMed ID: 4530824 [No Abstract] [Full Text] [Related]
3. Recombinant toxins as novel therapeutic agents. Pastan I; Chaudhary V; FitzGerald DJ Annu Rev Biochem; 1992; 61():331-54. PubMed ID: 1497314 [No Abstract] [Full Text] [Related]
4. Selective killing of laryngeal carcinoma cells by a monoclonal immunotoxin. Zenner HP Ann Otol Rhinol Laryngol; 1986; 95(2 Pt 1):115-20. PubMed ID: 3963684 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activities of conjugates of human transferrin and A subunits of plant toxins both in vitro and in vivo. Tonevitsky AG; Demina IA; Agapov II; Fattakhova GV; Popova EN; Moysenovich MM; Komolov IS; Khalanskii AS; Kirpichnikov MP Dokl Biochem; 2000; 374(1-6):210-3. PubMed ID: 11109967 [No Abstract] [Full Text] [Related]
7. Delivery into cells: lessons learned from plant and bacterial toxins. Sandvig K; van Deurs B Gene Ther; 2005 Jun; 12(11):865-72. PubMed ID: 15815697 [TBL] [Abstract][Full Text] [Related]
9. Toxin effect on protein biosynthesis in eukaryotic cells: a simple kinetic model. Skakauskas V; Katauskis P; Skvortsov A; Gray P Math Biosci; 2015 Mar; 261():83-90. PubMed ID: 25572165 [TBL] [Abstract][Full Text] [Related]
10. Biotoxins for cancer therapy. Liu CC; Yang H; Zhang LL; Zhang Q; Chen B; Wang Y Asian Pac J Cancer Prev; 2014; 15(12):4753-8. PubMed ID: 24998537 [TBL] [Abstract][Full Text] [Related]
11. Natural and Designed Toxins for Precise Therapy: Modern Approaches in Experimental Oncology. Shilova O; Shramova E; Proshkina G; Deyev S Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067057 [TBL] [Abstract][Full Text] [Related]
12. Immunotoxins and toxin constructs in the treatment of leukemia and lymphoma. Rosenblum M Adv Pharmacol; 2004; 51():209-28. PubMed ID: 15464911 [No Abstract] [Full Text] [Related]
13. Recombinant molecules may mean improved toxin therapies. Bowersox J J Natl Cancer Inst; 1992 Oct; 84(19):1466-8. PubMed ID: 1433327 [No Abstract] [Full Text] [Related]
15. Antibody-toxin conjugates: a new approach to cancer therapy. McIntosh DP Adv Biotechnol Processes; 1984; 3():111-39. PubMed ID: 6399840 [No Abstract] [Full Text] [Related]
16. Introduction to special issue: targeted toxins for glioma therapy. Puri RK J Neurooncol; 2003 Oct; 65(1):1-2. PubMed ID: 14649880 [No Abstract] [Full Text] [Related]
17. The inhibitory effect of crystalline ricin in Ehrlich ascites tumor. Lin JY; Lin LT; Chen CC; Tserng KY; Tung TC Taiwan Yi Xue Hui Za Zhi; 1970 Jan; 69(1):53-7. PubMed ID: 5271321 [No Abstract] [Full Text] [Related]
18. Toxins and derivatives in molecular pharmaceutics: Drug delivery and targeted therapy. Zhan C; Li C; Wei X; Lu W; Lu W Adv Drug Deliv Rev; 2015 Aug; 90():101-18. PubMed ID: 25959429 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies as carriers of toxins. Uhr JW; Fulton RJ; Till MA; May RD; Vitetta ES Prog Clin Biol Res; 1989; 288():403-12. PubMed ID: 2785694 [No Abstract] [Full Text] [Related]
20. Lymphocyte targeted ricin as a potential therapy for lymphoid malignancy. I. Targeting efficiency. Ramsden CS; Drayson MT; Bell EB Br J Cancer; 1991 May; 63(5):699-704. PubMed ID: 2039695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]